ProMIS Neurosciences PMN
NASDAQ PMN
$14.51 -0.40 (-2.68%)
As of: Aug 21, 2026 · 3:59 PM EDT

ProMIS Neurosciences (PMN) Interest Expenses (2021 - 2026)

ProMIS Neurosciences' (PMN) quarterly Interest Expenses came in at $71560.0 in Q1 2026, down 99.83% on a QoQ basis from $41.0 million in Q4 2025.

ProMIS Neurosciences (PMN) Interest Expenses (2021 - 2026) Analysis & Trends

ProMIS Neurosciences (PMN) has 6 years of Interest Expenses data on file, last reported at $71560.0 in Q1 2026.

  • Quarterly Interest Expenses changed N/A year-over-year to $71560.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71560.0 (down 52.99% YoY) and the FY2025 annual result came in at $41.0 million, up 28.61% from the prior year.
  • Interest Expenses declined to $71560.0 in Q1 2026, from $41.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $41.0 million in Q4 2025 to a low of $4842.0 in Q3 2022.
  • A 5-year average of $3.8 million and a median of $75413.0 in 2023 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2022 — Interest Expenses sank 96.56% — and 2023, when it jumped 1457.48%.
  • Tracing PMN's Interest Expenses over 5 years: stood at $4842.0 in 2022, then soared by 1486.02% to $76795.0 in 2023, then sank by 79.17% to $16000.0 in 2024, then jumped by 256185.76% to $41.0 million in 2025, then sank by 99.83% to $71560.0 in 2026.
  • The last three Interest Expenses figures came in at $71560.0 (Q1 2026), $41.0 million (Q4 2025), and $16000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 39.74 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 82.05 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -4.89 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 20.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 93.62 Mn
10 ProMIS Neurosciences 132.34 Mn 78.87 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2026 2.14 Mn
Jun 30, 2026 2.14 Mn
Mar 31, 2026 71,560.00
Mar 31, 2026 71,560.00
Dec 31, 2025 41.01 Mn
Dec 31, 2025 41.01 Mn
Sep 30, 2024 16,000.00
Sep 30, 2024 16,000.00
Jun 30, 2024 66,000.00
Jun 30, 2024 66,000.00
Mar 31, 2024 150,760.00
Mar 31, 2024 150,760.00
Dec 31, 2023 76,795.00
Dec 31, 2023 76,795.00
Sep 30, 2023 75,413.00
Sep 30, 2023 75,413.00
Jun 30, 2023 49,182.00
Jun 30, 2023 49,182.00
Sep 30, 2022 4,842.00
Sep 30, 2022 4,842.00